Twist Enterprise Value Over E B I T D A from 2010 to 2024

TWST Stock  USD 41.90  1.07  2.62%   
Twist Bioscience Enterprise Value Over EBITDA yearly trend continues to be comparatively stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -6 in 2024. From the period from 2010 to 2024, Twist Bioscience Enterprise Value Over EBITDA quarterly data regression had mean square error of  64.22 and mean deviation of  5.12. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(5.71)
Current Value
(6.00)
Quarterly Volatility
7.8916891
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist main balance sheet or income statement drivers, such as Tax Provision of 1.1 M, Net Interest Income of 17.3 M or Interest Income of 17.3 M, as well as many exotic indicators such as Price To Sales Ratio of 5.14, Dividend Yield of 0.0 or PTB Ratio of 1.9. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
This module can also supplement Twist Bioscience's financial leverage analysis and stock options assessment as well as various Twist Bioscience Technical models . Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Twist Bioscience Corp over the last few years. It is Twist Bioscience's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Pretty Stable
   Enterprise Value Over E B I T D A   
       Timeline  

Twist Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(8.79)
Coefficient Of Variation(89.74)
Mean Deviation5.12
Median(6.28)
Standard Deviation7.89
Sample Variance62.28
Range26.3247
R-Value(0.21)
Mean Square Error64.22
R-Squared0.04
Significance0.46
Slope(0.36)
Total Sum of Squares871.90

Twist Enterprise Value Over E B I T D A History

2024 -6.0
2023 -5.71
2022 -4.97
2021 -6.54
2020 -30.86
2019 -25.11
2018 -5.81

About Twist Bioscience Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Twist Bioscience income statement, its balance sheet, and the statement of cash flows. Twist Bioscience investors use historical funamental indicators, such as Twist Bioscience's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may use each financial statement separately, they are all related. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Twist Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Twist Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Twist Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(5.71)(6.00)
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:
Check out the analysis of Twist Bioscience Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.36)
Revenue Per Share
4.834
Quarterly Revenue Growth
0.251
Return On Assets
(0.16)
Return On Equity
(0.30)
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.